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M1 andM2Microglia Exhibit Significant Differences in their KD Channel
Expression
Eva Melanie Grossinger1, Hai Minh Nguyen1, Yi-Je Chen1,
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Davis, Sacramento, CA, USA.
Microglia effector functions are widely associated with specific phenotypes,
which are referred to as M1 and M2. Classically activated M1 microglia
release pro-inflammatory cytokines and neurotoxic molecules and have been
associated with neurological damage in ischemic stroke and Alzheimer’s dis-
ease. Alternatively activated M2 microglia exhibit beneficial immunological
effector functions such as phagocytosis of debris and release of anti-
inflammatory and neurotrophic factors. Similar to B- and T-cells, microglia
activity is regulated by calcium (Ca2þ)-signaling, which is maintained by po-
tassium (Kþ) channels. We here investigated whether M1 and M2 microglia
differ in their Kþ channel expression by differentiating neonatal mouse
microglia into M1 and M2 phenotypes using lipopolysaccharide (LPS)
and/or interferon-gamma or IL-4 and studying the cells by whole-cell
patch-clamp. We identified three types of Kþ channels based on their bio-
physical and pharmacological fingerprints: a use-dependent, outwardly recti-
fying current sensitive to the Kv1.3 blockers PAP-1 and ShK-L5, an inwardly
rectifying Ba2þ-sensitive Kir2.1 current, and a Ca2þ-activated, TRAM-34-
sensitive KCa3.1 current. M1 microglia, obtained by stimulation with LPS
or a combination of LPS and interferon-gamma exhibited high Kv1.3 current
densities (~ 30-60 pA/pF at 40 mV) and virtually no KCa3.1 and Kir currents,
while IL-4 stimulated M2 microglia exhibited large Kir currents (~ 10 pA/pF
at 120 mV). KCa3.1 currents were generally low but moderately increased
following stimulation with interferon-gamma or ATP. This differential
Kþ channel expression pattern suggests that Kþ channel modulators could
be used to selectively inhibit detrimental neuroinflammatory functions of
microglia.
This work was supported by RO1 GM076063 and RO1 AG043788A1 from
the NIH.
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Atherogenic Very-Low-Density Lipoprotein Shortens Atrial Action Poten-
tial Duration by Increasing Potassium Currents and Calcium Transient
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Background: Compared to that of healthy normal subjects, plasma very
low density lipoprotein (VLDL) of patients with the metabolic syndrome
(MetS) has been shown to be more electronegative and atherogenic.
Given the association between MetS and increased prevalence of atrial
fibrillation (AF), we investigated the mechanistic role of VLDL in the
AF pathogenesis.
Methods: We extracted VLDL via peripheral blood obtained from normal,
healthy volunteers and MetS individuals. The normal-VLDL and MetS-
VLDL samples were treated to HL-1 atrial cardiomyocytes respectively for
12 hours before experiments. Whole-cell patch clamp was used for recording
the action potentials, voltage-gated potassium currents, and L-type calcium cur-
rents. Calcium image with Fura-2-AMCa2þ indicator was applied for the intra-
cellular calcium measurements.
Results: MetS-VLDL treated HL-1 cells exhibited significantly higher den-
sities of repolarizing potassium currents, IKs and IKr. MetS-VLDL shifted
the activation curve of ICaL toward more negative membrane potentials.
Intracellular calcium signals were significantly enhanced by MetS-VLDL
but not by normal-VLDL. MetS-VLDL significantly shortened action poten-
tial durations (MetS-VLDL 178.1 5 32.0 msec vs control 257.2 5 52.7
msec; P¼0.0017). Addiotnally, frequent occurrences of early after-
depolarization on action potentials were noted in MetS-VLDL treated HL-1
cells.
Conclusions: The VLDL of MetS individuals augmented repolarizing potas-
sium currents, increased intracellular calcium release, and significantly short-
ened action potentials. These changes may contribute in coordination to
increased AF vulnerability in MetS.2960-Pos Board B390
New Insight into the Involvement of Large-Conductance Calcium-
Activated-Potassium-Channel(BK) in Cell Viability: Pathophysiological
Implications in Neuromuscular Disorders
Angela Curci, Antonietta Mele, Giulia Maria Camerino, Diana Conte,
Domenico Tricarico.
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The large conductance Ca2þ-activated Kþ-channel (BK) is involved in several
pathophysiological conditions including periodic paralysis (PP) and myotonia.
Acetazolamide (ACTZ) a carbonic anhydrase inhibitor used in these con-
ditions, acts targeting BK in PP. Here we investigated the involvement of BK
channel in neuronal viability (SH-SY5Y cell) by combining patch-clamp
technique and cell proliferation assays. We performed these measurements
in the presence or absence of the selective BK channel blocker Iberiotoxin
(IbTX) (10-400x109M), the unselective Kþ-channels blocker Tetraethylam-
monium (TEA) (0.01-1x103M), and the BK channel openers NS1619 (10-
100x105M) and ACTZ (0.1-200x106M). Patch-clamp recordings showed
that atþ30mV (Vm) IbTX and TEA reducedwhole cell Kþ-current in a concen-
tration -dependent manner with an Imax of 46% and 90% respectively.
NS1619 enhanced Kþ-current of þ141% at 10mV (Vm). Acetazolamide,
that in muscle acts as a BK opener, in neurons caused a concentration-
dependent block of Kþ-current at þ30mV(Vm) with an IC50 of 1.73x107M
an Imax of 40% (slope¼0.37) (Number of patches¼12). These drugs exert
their effects also on neuronal cell viability, enhancing it: IbTX showed a
maximal proliferative effect (MPE) ofþ46% at 108M concentration, reducing
it at higher concentrations; TEA showed a concentration-dependent increase of
cell proliferation with a MPE of þ34% at a 104M concentration; NS1619 and
ACTZ showed a MPE of þ181.6% at 5x105M and þ135% at 100x106M
concentration respectively. Staurosporine (STS) (2x10-6M), a broad spectrum
protein kinases inhibitor, prevented the IbTX and TEA proliferative action.
These results suggest that BK channel may play a role in the regulation of
neuronal viability through an intracellular pathway that involves STS-sensitive
protein kinases. These findings may have relevance in the cellular repair mech-
anisms in the neuromuscular disorders. Supported by Telethon GG14096.
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Long-Term Modulation of Ion Channels by Aldosterone in Adult Rat
Atrial Myocytes
Erick B. Rios-Perez, Maricela Garcı´a-Castan˜eda, Guillermo Avila.
Cinvestav, IPN, Mexico, Mexico.
In recent years, both aldosterone and mineralocorticoid receptor (MR) have
drawn attention as important factors that promote structural remodeling of
the atrium. Here, we investigated effects of chronic aldosterone treatment on
both intracellular Ca2þ and ion channels. Atrial myocytes were cultured in
either the absence or presence of aldosterone, and then the activity of ion chan-
nels was studied, under whole-cell patch-clamp conditions. Aldosterone
increased both the cell membrane capacitance (Cm) and the maximal conduc-
tance of ion channels that give rise to IKsus, INa, ICaT, and ICaL (30-100%).
Except for inactivation curves of INa, which were shifted by 10 mV, aldoste-
rone produced no major alterations in the biophysical properties of the chan-
nels. Interestingly, at resting membrane potentials the increase in INa was
cancelled by a greater fraction of inactivation. The onset and recovery of the
changes -in ICaT, ICaL, and Cm- were also assessed. In general, they required
2d to be noticeable, reached their maximal value in 6d, and returned to basal
values after 1-3d of aldosterone removal. The effects on both Cm and ICaL
were further studied -to explore both a potential dose-response relationship
and a possible implication of the MR. In fact, co-incubating with 10 mM of spi-
ronolactone (an MR antagonist) abolished both effects. Furthermore, their cor-
responding magnitudes fitted well with the Hill equation, being the EC50
values for Cm and ICaL 20 and 130 (nM), respectively. Interestingly, aldoste-
rone did not alter expression levels of Cav1.2, suggesting that the action on
ICaL arises from a stimulus in open probability. The hormone also produced
a 40% increase in the amplitude of Ca2þ transients along with a higher propor-
tion of arrhythmic cells (2.5-fold increase). These results contribute to under-
standing the role of the MR and aldosterone in atrial electrophysiology.
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The Anti-Proliferative Effect of Cation Channel Blockers on T Lympho-
cytes Stimulated by Anti-CD3 and Anti-CD28
Zoltan Varga, Zoltan Petho, Andras Balajthy, Adam Bartok, Sandor Somodi,
Orsolya Szilagyi, Gyorgy Panyi.
Dept. of Biophysics and Cell Biology, University of Debrecen, Debrecen,
Hungary.
The ion channels of T lymphocytes form a crucial part of the healthy immune
system, as they are important for cellular activation and proliferation. In
Wednesday, February 11, 2015 587aautoimmune diseases, effector memory T cells have a unique ion channel
pattern, therefore they are promising therapeutic targets. A number of ion chan-
nel inhibitors are known as selective inhibitors of T lymphocyte proliferation,
but the data available is contradictory. Our aim was to elucidate this phenom-
enon by investigating how the blockage of ion channels affects the activation
and proliferation of T cells treated previously with different concentrations
of mitogens.
In our experiments human peripheral blood lymphocytes from volunteers were
activated via monoclonal antibodies affecting the TCR-CD3 complex on the
cell surface and the co-stimulator molecule CD28. We applied specific ion
channel blockers acting on the major cationic channels of the T cell, the
Kv1.3, the KCa1.1 and the CRAC channel, either alone or in combination
with rapamycin, the inhibitor of the mammalian target of rapamycin
(mTOR). Five days after the stimulus flow cytometry measurements were per-
formed to determine the extent of cellular viability and proliferation.
Our measurements indicated that ion channel blockers and rapamycin had a
negative dose-dependent effect on the amount of cell division. Simultaneous
application of blockers for each channel along with rapamycin proved to be
the most effective, which indicates that they affect independent regulation
pathways. Upon increasing the rate of stimulation, the anti-proliferative effect
of the blockers diminished. This phenomenon was unknown to date and may
prove to be important in understanding the fine-tuning of T cell activation.
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Proton Channels are Present in Cell Membranes of the Breast Cancer Cell
Line MDA MB 231 and Affect Recovery from an Acid Load
Deri Morgan1, Patrick McIntire1, Vladimir Cherny1, Susan Smith2,
Boris Musset3, Thomas DeCoursey1.
1Molecular Biophysics, Rush University Medical Center, Chicago, IL, USA,
2Department of Biology & Physics, Kenshaw State University, Kennesaw,
GA, USA, 3Institute of Complex Systems, Forschungszentrum Ju¨lich, Ju¨lich,
Germany.
Voltage gated proton channels (HV1) have been implicated in late stage breast
cancer (Wang et al, 2012. J. Biol. Chem. 287:13877), where HV1 expression
correlated with tumor size and poor prognosis. HV1 knockdown reduced cell
proliferation and migration as well as matrix metalloprotease release. However,
the presence of functional HV1 on cancer cell membranes has not been demon-
strated and the mechanism by which they affect the function of these cells has
not been elucidated.
Here we show the definitive presence of functional HV1 on the membranes of
MDAMB 231 cells, a highly metastatic triple negative cell line. We performed
patch clamp experiments on these cells and were able to detect bona fide
voltage- and pH-gated channels that were perfectly selective for protons. The
membrane density of the channels in these cells was recorded as 3.5 pA/pF
which is roughly 5-fold lower than the 15 pA/pF displayed in neutrophils. In
order to show that HV1 expresses at a level sufficient to impact pH regulation
within these cells, we acid loaded them using the ammonium prepulse tech-
nique and monitored pHi recovery utilizing SEER with SNARF-1. Inhibiting
HV1 with 1 mM Zn2þ slowed recovery from an acid load by 3-fold, demon-
strating that the expression of HV1 on these cells affects pH regulation in
these cells.
We conclude that one mechanism by which HV1 may influence the patho-
physiology of breast cancer is by improving the ability of breast cancer cells
to regulate their internal pH.
Supported by the Bears Care and the Brian Piccolo fund.
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TOK1 Potassium Channels in Phytopathogenic Fungi
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Fungal plant pathogens are a significant threat to crop yield and global food
security and the search for pathogen-specific agricultural fungicide targets is
of high priority. TOK1 is a structurally and functionally unique plasma mem-
brane potassium (Kþ) channel with no known homologues in plants or animals
and is the only passive Kþ ion efflux pathway in fungi. Activation of TOK1
leads to ion dyshomeostasis and cell death. However, little is known about
TOK1 channels in phytopathogenic fungi. Here we describe the distribution,
evolution and molecular conservation of TOK1 homologues across plant fungal
phyla, and the cloning and characterization of TOK1 channels from two phy-
topathogens of significant socio-economic importance. In-silico bioinformatics
identified genes predicted to encode putative TOK1 protein subunits, conform-
ing to the characteristic eight transmembrane domain two pore domain (8TM/
2P) structure, in 204/231 sequenced fungal genomes analysed. Molecular con-servation of TOK1 primary structure was greatest in both pore domains and
flanking pore lining transmembrane domains, TM6 and TM8. MgTOK1 from
Mycosphaerella graminicola (wheat leaf blotch) and FgTOK1 from Fusarium
graminearum (wheat head blight) were cloned by RT-PCR into an expression
vector. cRNA was transcribed in-vitro and injected into Xenopus laevis oocytes
and ionic currents measured by two-electrode voltage clamp after 24-48 hours.
Both cloned TOK1 channels exhibited Kþ selective, non-inactivating,
strongly outwardly-rectifying Kþ currents whose activation threshold was
strictly determined by the transmembrane Kþ gradient, as revealed by isotonic
replacement of extracellular Naþ with Kþ. Channels varied in their voltage-
dependent activation kinetics and distinct from the canonical TOK1 isolate
from Saccharomyces cerevisae, displayed signs of time-dependent deactiva-
tion. This appears to be the first reported molecular identification and charac-
terisation of TOK1 Kþ channels from plant pathogenic fungi.
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KCa1.1 (BK) Channels on Fibroblast-Like Synoviocytes: A Novel Thera-
peutic Target for Rheumatoid Arthritis
Mark R. Tanner1, Zoltan Petho2, Rajeev B. Tajhya1, Redwan Huq1,
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1Department of Molecular Physiology and Biophysics, Baylor College of
Medicine, Houston, TX, USA, 2Biophysics and Cell Biology, University of
Debrecen, Debrecen, Hungary, 3Division of Rheumatology, Icahn School of
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Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease attacking
principally freely-moveable joints and affecting approximately 1.3 million in
the US. Recently, joint-resident fibroblast-like synoviocytes in RA (RA-FLS)
have been implicated in disease pathogenesis. We have shown that KCa1.1
is the predominant potassium channel expressed by RA-FLS and by FLS
from the pristane-induced arthritis (PIA) rat model of RA. Blocking KCa1.1
with paxilline or iberiotoxin or reducing its expression with siRNA inhibited
the production of pro-inflammatory cytokines, chemokines, and proteases,
and the invasiveness of both RA- and PIA-FLS. In contrast, the over-
expression of KCa1.1 increased the invasiveness of PIA-FLS and induced
the invasiveness of healthy rat FLS. These data demonstrate a crucial role of
KCa1.1 in regulating the aggressive behavior of FLS during RA.
We induced two models of RA in rats, moderate PIA and severe complete
Freund’s adjuvant collagen-induced arthritis. Treatment with the small mole-
cule KCa1.1 blocker paxilline, starting after onset of clinical signs, significantly
reduced disease severity in both models. However, paxilline can cross the
blood-brain barrier and block all variants of KCa1.1 throughout the body,
thereby inducing side effects that preclude its use as a therapeutic for human
use without significant modification. A strategy to target KCa1.1 on RA-FLS
without side effects in other tissues involves the identification of the b and g
regulatory subunits of KCa1.1 in RA-FLS through qPCR, western blotting,
and patch-clamp electrophysiology. This has the potential for the development
of blockers that selectively target KCa1.1 on RA-FLS and do not enter the cen-
tral nervous system.
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Kidney CLC-K Chloride Channels Inhibitors: Definition of Novel Struc-
tural Requirements and Efficacy in CLC-K Polymorphism Associated
with Hypertension
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The human chloride channels CLC-Ka and CLC-Kb play a pivotal role in kid-
ney by controlling chloride and water absorption. Both channels require barttin
as an accessory subunit for full activity. Mutations in CLC-Kb and barttin genes
lead to severe renal salt loss while CLC-K gain of function polymorphisms
could predispose to hypertension. Thus, compounds that selectively bind to
CLC-Ka and/or CLC-Kb channels may have a significant therapeutic potential.
Recently, we explored the pharmacological profile of CLC-K/barttin expressed
in mammalian HEK-293 cells and demonstrated that HEK cells represent a
valid biological system to screen CLC-K high affinity blockers (Imbrici et
al., Biochim Biophys Acta, 2014). Here, by using molecular modeling and
patch-clamp technique, we developed a new series of benzofuran derivatives
and evaluated their efficacy on CLC-K channels expressed in HEK 293 cells.
Chemical modifications regarding the hydrophobic group at C-5 and C-3 posi-
tion of the benzofuran nucleus of the lead compounds RT-93 and JBL-44 (IC50
within 10-30 mM range), allowed us to define the structural requirements to
ensure an efficacious CLC-Ka block, finally identifying SRA-36 the most
potent compound so far described, with an IC50 of 2.65 1 mM. Interestingly,
